Duration of Response in a Phase 3 Study of Sarilumab Plus Methotrexate in Patients with Active, Moderate-to-Severe Rheumatoid Arthritis Genovese, M. C., Mangan, E. K., Kimura, T., Iglesias-Rodriguez, M., Huizinga, T. J. WILEY. 2017

View details for Web of Science ID 000411824105321